[1] Price, T.R., Manolio, T.A., Kronmal, R.A., Kittner, S.J., Yue, N.C., Robbins, J., Anton-Culver, H. and O’Leary, D.H. (1997) Silent Brain Infarction on Magnetic Resonance Imaging and Neurological Abnormalities in Community-Dwelling Older Adults. The Cardiovascular Health Study. Stroke, 28, 1158-1164.
http://dx.doi.org/10.1161/01.STR.28.6.1158
[2] Fisher, C.M. (1965) Lacunes: Small, Deep Cerebral Infarcts. Neurology, 15, 774-784.
http://dx.doi.org/10.1212/WNL.15.8.774
[3] American Diabetes Association (2010) Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 33, S62-S69.
http://dx.doi.org/10.2337/dc10-S062
[4] Brant-Zawadzki, M., Fein, G., Van Dyke, C., Keirman, R., Davenport, L. and De Groot, J. (1985) MR Imaging of the Aging Brain. American Journal of Neuroradiology, 6, 675-682.
[5] Price, T.R., Manolio, T.A., Kronmal, R.A., Kittner, S.J., Yue, N.C., Robbins, J., Anton-Culver, H. and O’Leary, D.H. (1997) Silent Brain Infarction on Magnetic Resonance Imaging and Neurological Abnormalities in Community-Dwelling Older Adults. Stroke, 28, 1158-1164.
http://dx.doi.org/10.1161/01.STR.28.6.1158
[6] Ezekowitz, M.D., James, K.E., Nazarian, S.M., Davenport, J., Broderick, J.P., Gupta, S.R., Thadani, V., Meyer, M.L. and Bridgers, S.L. (1995) Silent Cerebral Infarction in Patients with Nonrheumatic Atrial Fibrillation. The Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. Circulation, 92, 2178-2182.
http://dx.doi.org/10.1161/01.CIR.92.8.2178
[7] Xavier, A.R., Qureshi, A.I., Kirmani, J.F., Yahia, A.M. and Bakshi, R. (2003) Neuroimaging of Stroke: A Review. Southern Medical Journal, 96, 367-379.
[8] Kase, C.S., Wolf, P.A., Chodosh, E.H., Zacher, H.B., Kelly-Hayes, M., Kannel, W.B., D’Agostino, R.B. and Scampini, L. (1989) Prevalence of Silent Stroke in Patients Presenting with Initial Stroke: The Framingham Study. Stroke, 20, 850-852.
http://dx.doi.org/10.1161/01.STR.20.7.850
[9] Davis, P.H., Clarke, W.F., Bendixen, B.H., Culebras, A., Adams, H.P. and Woolson, R.F. (1994) Silent Stroke in Patients Enrolled in the TOAST Study. Neurology, 44, A225.
[10] Chodosh, E.H., Foulkes, M.A., Kase, C.S., Wolf, P.A., Mohr, J.P., Hier, D.B., Price, T.R. and Furtado, J.G. (1988) Silent Stroke in the NINCDS Stroke Data Bank. Neurology, 38, 1674-1679.
http://dx.doi.org/10.1212/WNL.38.11.1674
[11] Jorgensen, H.S., Nakayama, H., Raaschou, H.O., Gam, J. and Olsen, T.S. (1994) Silent Infarction in Acute Stroke Patients: Prevalence, Localization, Risk Factors and Clinical Significance: The Copenhagen Stroke Study. Stroke, 25, 97-104.
http://dx.doi.org/10.1161/01.STR.25.1.97
[12] Herderschee, D., Hidra, A., Algna, A., Koudstaal, P.J., Kappelle, L.J. and Van Gijn, J. (1992) Silent Stroke in Patients with Transient ischemic Attack or Minor Ischemic Stroke. Stroke, 23, 1220-1226.
http://dx.doi.org/10.1161/01.STR.23.9.1220
[13] Bryan, R.N., Wells, S.W., Miller, T.J., Elster, A., Jungreis, C., Poirier, V., Lind, B. and Manolio, T.A. (1997) Prevalence and Anatomic Characteristics of Infarct-Like Lesions on MRI in the Elderly: Data from the Cardiovascular Health Study (CHS). Radiology, 202, 47-54.
http://dx.doi.org/10.1148/radiology.202.1.8988191
[14] Kumar, V., Fausto, N., Abbas, A.K., Cotran, R.S. and Robbins, S.L. (2005) Robbins and Cotran Pathologic Basis of Disease. 7th Edition, Saunders, Philadelphia, 1194-1195.
[15] Gardner, D. and Shoback, D. (2011) Greenspan’s Basic & Clinical Endocrinology. 7th Edition, McGraw-Hill Medical, New York, Chapter 17.
[16] Nakamura, T., Kawagoe, Y., Matsuda, T., Ueda, Y., Ebihara, I. and Koide, H. (2005) Silent Cerebral Infarction in Patients with Type 2 Diabetic Nephropathy. Effects of Antiplatelet Drug Dilazepdihydrochloride. Diabetes/Metabolism Research and Reviews, 21, 39-43.
http://dx.doi.org/10.1002/dmrr.473